Xenotransplantation is a medical procedure involving the transplantation of organs, tissues, or cells from one species to another, with a notable focus on utilizing pig organs for human transplantation. Pigs are often chosen due to physiological similarities with humans and the availability of large, genetically modified pig herds for xenotransplantation purposes. This innovative approach seeks to address the shortage of human donor organs for transplantation, a significant global healthcare challenge. However, xenotransplantation faces substantial immunological barriers, particularly the risk of hyperacute rejection, where the recipient's immune system rapidly attacks the xenograft. Researchers have employed genetic engineering to modify pigs to reduce immunological incompatibilities and mitigate the risk of rejection. The potential success of xenotransplantation could revolutionize organ transplantation, offering a more abundant and readily available source of organs. Ethical and safety concerns, including the risk of zoonotic infections and long-term consequences, must be thoroughly addressed before widespread clinical implementation. Ongoing research aims to refine xenotransplantation techniques, enhance the compatibility of pig organs with the human immune system, and establish comprehensive regulatory frameworks to ensure the safety and ethical considerations of this promising medical frontier.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States